[Pj-083] Japanese Poster Session 083

[Pj-083-5] Safety and amyloid plaque reduction effects of remternetug in patients with Alzheimer's disease

Mitsuru Ishibai¹, Yan Jin², Ivelina Gueorguieva³, Yun-ju Cheng², Ilke Tunali², Sergey Shcherbinin², David Perahia³, Krista Phipps², Kevin Biglan², Mark Mintun², Matan Dabora², Miroslaw Brys² (1.Eli Lilly Japan K.K., Kobe,, Japan, 2.Eli Lilly and Co, Indianapolis,, USA, 3.Eli Lilly and Co, Bracknell, UK)